PMID: 7032443Jan 1, 1982Paper

Hypertension in a patient with hypercalcemia: captopril and verapamil

Archives of Internal Medicine
B WaeberH Gavras

Abstract

A 38-year-old woman with hypercalcemia, severe hypertension, and high renin levels was treated with the angiotensin-converting enzyme inhibitor captopril. This therapy, together with spironolactone, normalized blood pressure (BP), but even with three daily administrations of the converting enzyme inhibitor, intermittent rebound hypertension could not be avoided. The administration of only verapamil, an antagonist of calcium transport, did not induce BP control, but when verapamil therapy was combined with administration of captopril and spironolactone, BP could be normalized with only twice-daily administration of the converting enzyme inhibitor. Thus, high plasma calcium levels seem to sensitize the arterioles to the intermittent increase of angiotensin II levels that accompanies captopril therapy.

Citations

Aug 1, 1986·Psychiatry Research·S L DubovskyJ Murphy
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·B WaeberH R Brunner
Oct 1, 1984·The American Journal of Medicine·R K FergusonH H Rotmensch
May 1, 1991·Metabolism: Clinical and Experimental·N L WongD C Hu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.